T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.76B |
| 2 |
Cigna
CI
|
+$1.44B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.26B |
| 4 |
Occidental Petroleum
OXY
|
+$763M |
| 5 |
Danaher
DHR
|
+$762M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$2.46B |
| 2 |
Wynn Resorts
WYNN
|
+$1.11B |
| 3 |
Netflix
NFLX
|
+$1.03B |
| 4 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$975M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$909M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.37% |
| 2 | Financials | 13.66% |
| 3 | Consumer Discretionary | 13.64% |
| 4 | Technology | 10.86% |
| 5 | Industrials | 10.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Assured Guaranty
AGO
$3.35B
| $121M | 0.02% |
5,025,631
-7,490
| -0.1% | -$209K |
|
552
Dominion Energy
D
$60.4B
| $120M | 0.02% |
1,801,180
+780,685
| +77% | +$54.9M |
|
553
Descartes Systems
DSGX
$6.51B
| $120M | 0.02% |
7,484,511
+1,088,832
| +17% | +$16.9M |
|
554
Tyson Foods
TSN
$20.4B
| $119M | 0.02% |
2,801,000
+2,308,321
| +469% | +$94.8M |
|
555
Meritage Homes
MTH
$4.81B
| $119M | 0.02% |
5,056,360
-525,740
| -9% | -$11.9M |
|
|
AAN.A
556
DELISTED
The Aaron's Company Inc Class A
AAN.A
| $119M | 0.02% |
3,278,314
-2,561,430
| -44% | -$92.7M |
|
557
Kinder Morgan
KMI
$72B
| $119M | 0.02% |
3,092,036
+154,509
| +5% | +$6.45M |
|
558
Innospec
IOSP
$2.31B
| $119M | 0.02% |
2,632,045
-423,105
| -14% | -$19M |
|
|
QUOT
559
DELISTED
Quotient Technology Inc
QUOT
| $118M | 0.02% |
10,901,053
+46,320
| +0.4% | +$580K |
|
560
Caterpillar
CAT
$397B
| $117M | 0.02% |
1,378,866
-120,950
| -8% | -$10.4M |
|
|
MHFI
561
DELISTED
MCGRAW-HILL FINANCIAL INC COM
MHFI
| $116M | 0.02% |
1,157,897
-19,912
| -2% | -$2.08M |
|
562
Highwoods Properties
HIW
$3.52B
| $115M | 0.02% |
2,890,165
+74,248
| +3% | +$3.2M |
|
563
Terreno Realty
TRNO
$7.52B
| $115M | 0.02% |
5,860,925
+252,935
| +5% | +$5.36M |
|
564
DuPont de Nemours
DD
$19.4B
| $115M | 0.02% |
883,810
+60,184
| +7% | +$7.8M |
|
|
JNS
565
DELISTED
Janus Capital Group Inc
JNS
| $113M | 0.02% |
6,621,145
-22,320
| -0.3% | -$399K |
|
566
St. Joe Company
JOE
$3.91B
| $113M | 0.02% |
7,277,088
+1,305,643
| +22% | +$21.9M |
|
567
ONE Gas
OGS
$5.09B
| $113M | 0.02% |
2,648,090
+1,696,110
| +178% | +$72.4M |
|
|
NATI
568
DELISTED
National Instruments Corp
NATI
| $112M | 0.02% |
3,807,895
-176,190
| -4% | -$5.42M |
|
|
KATE
569
DELISTED
Kate Spade & Company
KATE
| $112M | 0.02% |
5,191,529
-370,451
| -7% | -$10.7M |
|
570
DTE Energy
DTE
$29.1B
| $112M | 0.02% |
1,758,274
+1,085,086
| +161% | +$72.6M |
|
|
ADPT
571
DELISTED
Adeptus Health Inc
ADPT
| $112M | 0.02% |
1,175,770
+364,400
| +45% | +$25.1M |
|
572
Omnicom Group
OMC
$24.1B
| $111M | 0.02% |
1,603,259
-9,629
| -0.6% | -$727K |
|
|
CMCSK
573
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
| $110M | 0.02% |
1,843,072
-2,847,726
| -61% | -$171M |
|
574
Red Robin
RRGB
$171M
| $109M | 0.02% |
1,270,563
-39,650
| -3% | -$3.27M |
|
|
AEC
575
DELISTED
ASSOCIATED ESTATES REALTY CORP
AEC
| $108M | 0.02% |
3,769,990
-205,300
| -5% | -$5.67M |
|
Similar funds
T. Rowe Price Associates's Q2 2015 Portfolio in Review
As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
- T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
- T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
- T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
- T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
- T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
- T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.
Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.